14 results · 26ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

ONCOLOGY SALVAGE SYSTEM

FDA 510(k)
FDA Class 2 ·Orthopedic

RHK SEGMENTAL SHORT YOKE

FDA Adverse Event
Injury ·BIOMET UK LTD.·Product code JDI·December 7, 2016

DURA-CUF

FDA UDI
GE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC.·00840682109932·DURA-CUF, LARGE ADULT LONG, 2 TB MATED SUBMIN, ...

RANGER II M6, MODEL IN-888WNL

FDA 510(k)
FDA Class 2 ·Physical Medicine

BROOKER TIBIA NAILS

FDA 510(k)
FDA Class 2 ·Orthopedic

AUTOSOFT XC

FDA Adverse Event
Malfunction ·UNOMEDICAL A/S·Product code FPA·June 6, 2024

AUTOSOFT XC

FDA Adverse Event
Malfunction ·UNOMEDICAL A/S·Product code FPA·October 24, 2024

BD SYRINGE AND NEEDLE COMBINATION LUER-LOK¿¿ TIP

FDA Adverse Event
Malfunction ·BECTON DICKINSON MEDICAL SYSTEMS·Product code FMF·March 27, 2018

LUMAX 340 DR-T

FDA Adverse Event
Malfunction ·BIOTRONIK SE & CO. KG·Product code MRM·February 13, 2013

ASR UNI FEMORAL IMPL SIZE 45

FDA Adverse Event
Injury ·DEPUY INTERNATIONAL, LTD.·Product code KWA·February 17, 2011

9600

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS, INC.·Product code JAA·February 26, 2008

Dynamic Locking Screw System (DLS) 3.7mm & Dynamic Locking Screw (DLS) 5.0mm; intended for use in long bone fractures, the fixation of osteopenic bone, the fixation of osteotomies, and for the fixation of non-unions and malunions.

FDA Enforcement
Class II ·Terminated·Synthes (USA) Products LLC·September 30, 2015

1202 Flex Focus Ultrasound System, cart models UA1214 and UA1814, used with: Flex Focus 200, Flex Focus 300, Flex Focus 400, Flex Focus 500, Flex Focus 700, Flex Focus 800; System, Imaging, Pulsed Doppler, Ultrasonic

FDA Enforcement
Class II ·Ongoing·B-K Medical A/S·November 12, 2025

CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024